Sorted By:

Relevance


PhRMA Statement on 2014 Special 301 Report

PhRMA  |  Press Release

WASHINGTON, D.C. (April 30, 2014) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today: Maintaining global incentives for research and development into new medicines is essential for continue...
https://www.phrma.org/press-release/phrma-statement-on-2014-special-301-report

PhRMA Calls for Repeal of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit:  www.PhRMA.org .innovation.org/?
https://www.phrma.org/press-release/phrma-calls-for-repeal-of-the-ensuring-patient-access-and-effective-drug-enforcement-act-of-2016

New Report Shows 74 Percent of Medicines in Development have Potential to be First-in-Class Treatments

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit:  www.PhRMA.org   www.Innovation.org  www.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/new-report-shows-74-percent-of-medicines-in-development-have-potential-to-be-first-in-class-treatments

New Analysis: 340B Program Shifting Delivery of Physician-Administered Medicines to More Expensive Hospital Settings

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit:  www.PhRMA.org www.Innovation.org www.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/new-analysis-340b-program-shifting-delivery-of-physician-administered-medicines-to-more-expensive-hospital-settings

Las Compañías Biofarmacéuticas de Estados Unidos Lanzan una Innovadora Iniciativa Anunciando la Nueva Era de la Medicina

PhRMA  |  Press Release

WASHINGTON, D.C. (23 de enero de 2017) – Pharmaceutical Researchers & Manufacturers of America (PhRMA) lanzó hoy una iniciativa nacional, de publicidad y asuntos públicos en nombre de las compañías biofarmacéuticas de los Estados Unidos. La campaña, GOBOLDLY, mostrará a...
https://www.phrma.org/press-release/las-compa-as-biofarmac-uticas-de-estados-unidos-lanzan-una-innovadora-iniciativa-anunciando-la-nueva-era-de-la-medicina

PhRMA Statement on the United Nations High Level Panel Report on Access to Medicines

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-statement-on-the-united-nations-high-level-panel-report-on-access-to-medicines

2014 Economic Futures Report

PhRMA  |  Press Release

On Thursday, April 10, PhRMA will release a new report that outlines two potential growth trajectories for the U.S. biopharmaceutical sector and the top policy factors that enable the industry to innovate and, in turn, contribute to the U.S. economy.
https://www.phrma.org/press-release/2014-economic-futures-report

New analysis: More than half of patients’ out-of-pocket spending for brand medicines is based on full list price

PhRMA  |  Blog Post

According to a recent study from the Berkeley Research Group, more than a third of the list price for brand medicines is rebated back to payers and the supply chain.
http://catalyst.phrma.org/new-analysis-more-than-half-of-patients-out-of-pocket-spending-for-brand-medicines-is-based-on-full-list-price

PhRMA Statement on AARP Report

PhRMA  |  Press Release

., released a distorted and misleading report that doesn’t paint an accurate picture of prescription drug spending in the U.S.
https://www.phrma.org/press-release/phrma-statement-on-aarp-report

Medicines in Development for Vaccines

PhRMA  |  Press Release

Washington, D.C. (April 20, 2012)— America’s biopharmaceutical research companies are developing nearly 300 vaccines for the prevention and treatment of a wide variety of diseases, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). The ...
https://www.phrma.org/press-release/medicines-in-development-for-vaccines

5 Things to Know About the CMS Part D Data Release

PhRMA  |  Blog Post

The data released do not reflect the significant rebates and discounts Part D plans negotiate with pharmaceutical companies.
http://catalyst.phrma.org/5-things-to-know-about-the-cms-part-d-data-release

PhRMA & BIO release joint principles on communications with health care professionals and payers

PhRMA  |  Blog Post

Additionally, a “diverse group of health care stakeholders participating in an Academy of Managed Care Pharmacy (AMCP) forum reached agreement on a wide range of recommendations to make it easier for pharmaceutical companies to share pharmacoeconomic information with health care organizations that make coverage decisions.”
http://catalyst.phrma.org/phrma-bio-release-joint-principles-on-communications-with-health-care-professionals-and-payers

PhRMA Statement Regarding Pediatric Reauthorization

PhRMA  |  Press Release

Find PhRMA Online: Website – http://www.phrma.org facebook – www.facebook.com/PhRMA Blog – www.phrma.org/catalyst Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress YouTube – www.youtube.com/PhRMApress For information on how innovative medicines save lives, visit: http://www.innovation.org For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org
https://www.phrma.org/press-release/phrma-statement-regarding-pediatric-reauthorization

Statement on Biosimilar User Fee Act Reauthorization

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/statement-on-biosimilar-user-fee-act-reauthorization1

PhRMA Statement Regarding Authorized Generics

PhRMA  |  Press Release

(August 31, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett released the following statement: “PhRMA is still reviewing the details of the Federal Trade Commission’s report on authorized generics.
https://www.phrma.org/press-release/phrma-statement-regarding-authorized-generics

From Setbacks to Stepping Stones

PhRMA  |  Press Release

(September 13, 2012)— The Pharmaceutical Research and Manufacturers of America (PhRMA) released two new reports at its first annual Research and Hope Awards ceremony, which celebrated advancements made in research and patient care for Alzheimer’s disease.  
https://www.phrma.org/press-release/from-setbacks-to-stepping-stones

PhRMA Statement on Special 301 Report

PhRMA  |  Press Release

(May 2, 2012) — The Pharmaceutical Research and Manufacturers of America (PhRMA) released the following statement today on the Special 301 Report issued by the United States Trade Representative (USTR).
https://www.phrma.org/press-release/phrma-statement-on-special-301-report

New report highlights impact of intellectual property on U.S. economy

PhRMA  |  Blog Post

Department of Commerce released a comprehensive report that found intellectual property (IP) intensive industries contribute more than $6 trillion (38.2 percent) to U.S. gross domestic product (GDP).
http://catalyst.phrma.org/new-report-highlights-impact-of-intellectual-property-on-u.s.-economy

Research & Hope Awards

PhRMA  |  Press Release

Washington, D.C. (September 11, 2013) — The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the 2013 Research & Hope Awards, honoring outstanding achievements in vaccines research and imm...
https://www.phrma.org/press-release/research-and-hope-awards

India and Intellectual Property

PhRMA  |  Press Release

Washington, D.C. (December 30, 2013) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matt Bennett provided the following statement: “Innovation is critical to meeting patients’ unmet medical needs and is particularly relevant in the con...
https://www.phrma.org/press-release/india-and-intellectual-property

PhRMA Statement on MedPAC Recommendations

PhRMA  |  Press Release

Washington, D.C. (October 6, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matt Bennett issued the following statement on the Medicare Payment Advisory Commission’s (MedPAC) recommendations:   “PhRMA believes it is import...
https://www.phrma.org/press-release/phrma-statement-on-medpac-recommendations

PhRMA Statement on Bloomberg Article

PhRMA  |  Press Release

Washington, D.C. (September 19, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today: “An article published today by Bloomberg does not accurately reflect PhRMA’s position on Medicar...
https://www.phrma.org/press-release/phrma-statement-on-bloomberg-article

PhRMA Statement

PhRMA  |  Press Release

WASHINGTON, D.C. (November 17, 2013) Pharmaceutical Research and Manufacturers of America Senior Vice President of Communications Matthew Bennett made the following statement today:  "Today's New York Times story brings attention to some of the challenges related to ens...
https://www.phrma.org/press-release/phrma-statement

PhRMA: Compulsory Licensing in India

PhRMA  |  Press Release

Find PhRMA Online: Website – http://www.phrma.org facebook – www.facebook.com/PhRMA Blog – www.phrma.org/catalyst Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress YouTube – www.youtube.com/PhRMApress For information on how innovative medicines save lives, visit: http://www.innovation.org For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org
https://www.phrma.org/press-release/phrma-compulsory-licensing-in-india

PhRMA Statement on Patent Reform

PhRMA  |  Press Release

(March 9, 2011) — The Pharmaceutical Research and Manufacturers of America President and CEO John Castellani today released the following statement regarding the Senate passage of the patent reform bill: “We congratulate Senator Leahy and other Congressional leaders who supported the America Invents Act, including the members of the Senate Judiciary Committee, who previously came together for a bipartisan and unanimous committee vote.
https://www.phrma.org/press-release/phrma-statement-on-patent-reform1

You have reviewed the first 75 results out of 877. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next